Regulatory CD4+CD25+ T cells have been implicated in a number of pathologic processes including elevated levels of Treg cells in certain types of cancer [47-49] and infectious diseases [17,50-52], and reduced Treg levels in autoimmune diseases [9,53-56]. This evidence concerns the gene CD4 and cancer.